Barclays PLC Biomarin Pharmaceutical Inc Put Options Transaction History

Barclays PLC

$377 Billion
Q3 2024

Put Options

18 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 15, 2024	BUY	$69.02 - $93.84 $2.48 Million - $3.37 Million	35,900 New	35,900 $2.52 Million
Q1 2024 May 15, 2024	BUY	$83.81 - $99.0 $83,810 - $99,000	1,000 Added 2.02%	50,400 $4.4 Million
Q4 2023 Feb 15, 2024	BUY	$76.22 - $98.51 $3.77 Million - $4.87 Million	49,400 New	49,400 $4.76 Million
Q4 2021 Feb 14, 2022	BUY	$71.72 - $91.47 $11.1 Million - $14.1 Million	154,600 Added 364.62%	197,000 $17.4 Million
Q2 2021 Aug 13, 2021	SELL	$75.51 - $84.79 $8.88 Million - $9.97 Million	-117,600 Reduced 73.5%	42,400 $3.54 Million
Q4 2020 Feb 11, 2021	BUY	$72.61 - $90.2 $8.98 Million - $11.2 Million	123,700 Added 340.77%	160,000 $14 Million
Q2 2020 Aug 12, 2020	BUY	$79.55 - $124.22 $1.26 Million - $1.98 Million	15,900 Added 77.94%	36,300 $4.48 Million
Q1 2020 May 13, 2020	SELL	$71.37 - $96.85 $1.16 Million - $1.58 Million	-16,300 Reduced 44.41%	20,400 $1.72 Million
Q4 2019 Feb 10, 2020	SELL	$64.27 - $86.37 $1.75 Million - $2.35 Million	-27,200 Reduced 42.57%	36,700 $3.1 Million
Q3 2019 Nov 14, 2019	SELL	$67.4 - $85.11 $7.81 Million - $9.86 Million	-115,900 Reduced 64.46%	63,900 $4.31 Million
Q2 2019 Aug 14, 2019	SELL	$80.35 - $93.9 $4.26 Million - $4.98 Million	-53,000 Reduced 22.77%	179,800 $15.4 Million
Q1 2019 May 15, 2019	BUY	$84.2 - $98.62 $11.8 Million - $13.8 Million	139,900 Added 150.59%	232,800 $20.7 Million
Q4 2018 Feb 14, 2019	SELL	$80.14 - $106.07 $3.11 Million - $4.12 Million	-38,800 Reduced 29.46%	92,900 $7.91 Million
Q3 2018 Nov 14, 2018	SELL	$93.92 - $105.72 $3.96 Million - $4.46 Million	-42,200 Reduced 24.27%	131,700 $12.8 Million
Q2 2018 Aug 14, 2018	BUY	$76.01 - $99.03 $8.06 Million - $10.5 Million	106,000 Added 156.11%	173,900 $16.4 Million
Q1 2018 May 15, 2018	SELL	$77.67 - $92.63 $5.19 Million - $6.19 Million	-66,800 Reduced 49.59%	67,900 $5.51 Million
Q4 2017 Feb 14, 2018	BUY	$80.76 - $95.13 $2.21 Million - $2.61 Million	27,400 Added 25.54%	134,700 $12 Million
Q3 2017 Nov 14, 2017	BUY	$80.6 - $94.95 $8.65 Million - $10.2 Million	107,300	107,300 $9.99 Million

Others Institutions Holding BMRN

# of Institutions

635

Shares Held

178M

Call Options Held

2.01M

Put Options Held

1.28M

Black Rock Inc. New York, NY

22.7M
Shares

$1.44 Billion
0.04% of portfolio
Vanguard Group Inc Valley Forge, PA

19.3M
Shares

$1.22 Billion
0.02% of portfolio
Primecap Management CO Pasadena, CA

18.9M
Shares

$1.2 Billion
0.99% of portfolio
Dodge & Cox San Francisco, CA

13.9M
Shares

$881 Million
0.59% of portfolio
Capital Research Global Investors Los Angeles, CA

10.5M
Shares

$666 Million
0.16% of portfolio

View Full List

About BIOMARIN PHARMACEUTICAL INC

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $11.8B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

More about BMRN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.

Account